RxDoctor Payments Data

Jared Spector

Plastic Surgery within the Head & Neck · Cary, NCNPI 1629048004

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.

$5,127in general payments, 2019–2025

Across 241 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$834
  • GSK$784
  • AstraZeneca$509
  • Stryker$463
  • Medtronic$287
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$5,07199%
  • Education$561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few plastic surgery within the head & neck providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$136,221
Medicare patients
298
Services billed
4,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab46$182,794
Epinephrine19$4,313
Omeprazole75$1,989
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,956
Fluticasone Propionate33$634
Ipratropium Bromide33$613
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$246
Montelukast Sodium35$238
Ciprofloxacin Hcl15$221
Methylprednisolone26$162
Ondansetron OdtOndansetron13$131
Doxycycline Hyclate11$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAEpinephrine$33$4,31319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few plastic surgery within the head & neck providers in North Carolinaon file to place this against a meaningful peer group, so we don't.

Other plastic surgery within the head & neck in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →